Lenalidomide Based Immunotherapy in the Treatment of DLBCL

Clinical trial NCT03715296 · UNKNOWN

Trial details

NCT number: NCT03715296
Sponsor: Ruijin Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Diffuse Large B Cell Lymphoma

Start date: 2018-10-18
Primary completion: 2020-09-15
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.